Intervention Review

Polyunsaturated fatty acid supplementation for schizophrenia

  1. Claire B Irving1,*,
  2. Roger Mumby-Croft2,
  3. L A Joy3

Editorial Group: Cochrane Schizophrenia Group

Published Online: 19 JUL 2006

Assessed as up-to-date: 11 FEB 2009

DOI: 10.1002/14651858.CD001257.pub2

How to Cite

Irving CB, Mumby-Croft R, Joy LA. Polyunsaturated fatty acid supplementation for schizophrenia. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD001257. DOI: 10.1002/14651858.CD001257.pub2.

Author Information

  1. 1

    The University of Nottingham, Cochrane Schizophrenia Group, Nottingham, UK

  2. 2

    Westminster College, Oxford, UK

  3. 3

    Frampton Mansell, Gloucestershire, UK

*Claire B Irving, Cochrane Schizophrenia Group, The University of Nottingham, Institute of Mental Health, Sir Colin Campbell Building, University of Nottingham Innovation Park, Triumph Road, Nottingham, NG7 2TU, UK. Claire.Irving@nottingham.ac.uk. claireirving@btinternet.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 JUL 2006

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Maria Tabbaa, Mladen Golubic, Michael Roizen, Adam Bernstein, Docosahexaenoic Acid, Inflammation, and Bacterial Dysbiosis in Relation to Periodontal Disease, Inflammatory Bowel Disease, and the Metabolic Syndrome, Nutrients, 2013, 5, 8, 3299

    CrossRef

  2. 2
    Arthur Ryan, Allison Macdonald, Elaine Walker, The Treatment of Adolescents With Schizotypal Personality Disorder and Related Conditions: A Practice-Oriented Review of the Literature, Clinical Psychology: Science and Practice, 2013, 20, 4
  3. 3
    K. Akter, D. A. Gallo, S. A. Martin, N. Myronyuk, R. T. Roberts, K. Stercula, R. B. Raffa, A review of the possible role of the essential fatty acids and fish oils in the aetiology, prevention or pharmacotherapy of schizophrenia, Journal of Clinical Pharmacy and Therapeutics, 2012, 37, 2
  4. 4
    Stephen J. Wood, Alison R. Yung, Patrick D. McGorry, Christos Pantelis, Neuroimaging and Treatment Evidence for Clinical Staging in Psychotic Disorders: From the At-Risk Mental State to Chronic Schizophrenia, Biological Psychiatry, 2011, 70, 7, 619

    CrossRef

  5. 5
    John Bola, Dennis Kao, Haluk Soydan, Clive E Adams, Antipsychotic medication for early episode schizophrenia, The Cochrane Library,
  6. 6
    Robert Pearsall, Anthony Pelosi, John Geddes, Dietary advice for schizophrenia, The Cochrane Library,
  7. 7
    Andrew Campbell, Jackie Price, William R Hiatt, Omega-3 fatty acids for intermittent claudication, The Cochrane Library,